DK1037650T3 - Præparater til behandling af Staphylococcus aureus-infektioner - Google Patents

Præparater til behandling af Staphylococcus aureus-infektioner

Info

Publication number
DK1037650T3
DK1037650T3 DK98964810T DK98964810T DK1037650T3 DK 1037650 T3 DK1037650 T3 DK 1037650T3 DK 98964810 T DK98964810 T DK 98964810T DK 98964810 T DK98964810 T DK 98964810T DK 1037650 T3 DK1037650 T3 DK 1037650T3
Authority
DK
Denmark
Prior art keywords
treatment
preparations
staphylococcus aureus
aureus infections
infection
Prior art date
Application number
DK98964810T
Other languages
Danish (da)
English (en)
Inventor
James W Larrick
Susan C Wright
Naomi Balaban
Original Assignee
Naomi Balaban
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naomi Balaban filed Critical Naomi Balaban
Application granted granted Critical
Publication of DK1037650T3 publication Critical patent/DK1037650T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98964810T 1997-12-19 1998-12-18 Præparater til behandling af Staphylococcus aureus-infektioner DK1037650T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6809497P 1997-12-19 1997-12-19
US09/054,331 US6291431B1 (en) 1997-12-19 1998-04-02 Methods and compositions for the treatment and prevention of Staphylococcal infections

Publications (1)

Publication Number Publication Date
DK1037650T3 true DK1037650T3 (da) 2006-12-11

Family

ID=26732900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98964810T DK1037650T3 (da) 1997-12-19 1998-12-18 Præparater til behandling af Staphylococcus aureus-infektioner

Country Status (10)

Country Link
US (2) US6291431B1 (el)
EP (1) EP1037650B1 (el)
AT (1) ATE335499T1 (el)
AU (1) AU2005099A (el)
CY (1) CY1106234T1 (el)
DE (1) DE69835536T2 (el)
DK (1) DK1037650T3 (el)
ES (1) ES2270540T3 (el)
PT (1) PT1037650E (el)
WO (1) WO1999032133A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703374B1 (en) 1997-10-30 2004-03-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleosides for imaging and treatment applications
US20080219976A1 (en) * 1997-12-19 2008-09-11 Naomi Balaban Methods and compositions for treatment and prevention of staphylococcal infections
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US7534857B2 (en) * 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
EP1862549A3 (en) * 1998-09-15 2008-02-13 Naomi Balaban Target of RNAIII activating protein (TRAP)
EP1188831B1 (en) * 1998-09-15 2007-12-05 Naomi Balaban Target of RNAIII activating protein (TRAP)
JP2003522153A (ja) * 2000-02-10 2003-07-22 インターミューン インコーポレイテッド ブドウ球菌属ビルレンスの新規アミノ酸インヒビターおよびペプチドインヒビター
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
CN1569889A (zh) * 2003-07-21 2005-01-26 中国人民解放军军事医学科学院基础医学研究所 能与金葡菌自分泌的rnaiii激活蛋白结合的环多肽及其医药用途
EP1621203A1 (en) * 2004-07-27 2006-02-01 Genoscience RNAIII-inhibiting peptides for treating HIV infection
US7824691B2 (en) * 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
US20070015685A1 (en) * 2005-04-04 2007-01-18 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070092572A1 (en) * 2005-04-04 2007-04-26 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070009566A1 (en) * 2005-04-04 2007-01-11 Naomi Balaban Method and apparatus for treating bacterial infections in devices
CN101189020A (zh) * 2005-05-10 2008-05-28 N·巴拉班 用于给予rnaⅲ-抑制肽的组合物
WO2007061942A2 (en) 2005-11-18 2007-05-31 Glanbia Nutritionals (Ireland) Ltd. Compositions for disrupting and inhibiting reconstitution of wound biofilm
WO2007090123A2 (en) * 2006-01-30 2007-08-09 University Of Chicago Mgra is a redox regulator of antibiotic sensitivity and virulence
WO2007147098A2 (en) * 2006-06-16 2007-12-21 Tufts University Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections
WO2008129428A2 (en) * 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
US9777076B2 (en) 2012-07-16 2017-10-03 Pfizer Inc. Saccharides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3043362B2 (ja) 1989-04-27 2000-05-22 マクニール―ピーピーシー・インコーポレーテツド タンポンへの添加剤
AU3825995A (en) 1994-10-04 1996-04-26 New York University Blocking expression of virulence factors in s. aureus
AU735283B2 (en) 1996-05-22 2001-07-05 New York University Blocking expression of virulence factors in (s. aureus)
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections

Also Published As

Publication number Publication date
EP1037650B1 (en) 2006-08-09
WO1999032133A1 (en) 1999-07-01
US7067135B2 (en) 2006-06-27
CY1106234T1 (el) 2011-06-08
PT1037650E (pt) 2006-12-29
ES2270540T3 (es) 2007-04-01
US6291431B1 (en) 2001-09-18
DE69835536T2 (de) 2007-08-09
EP1037650A1 (en) 2000-09-27
US20040077534A1 (en) 2004-04-22
ATE335499T1 (de) 2006-09-15
EP1037650A4 (en) 2004-10-20
DE69835536D1 (de) 2006-09-21
AU2005099A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
EA200000840A1 (ru) Антивирусные производные пиримидина
ATE376996T1 (de) Antibakterielle mittel
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
IL189629A0 (en) Compositions containing human ctla-4 antibodies
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
PT1140993E (pt) Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ES2186916T3 (es) Derivados de isoxazolina como agentes antimicrobianos.
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DK1077718T3 (da) Forøgelse af aktiviteten af antibakterielle oxazolidinon-midler ved anvendelse af argininderivater
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
DE69318921T2 (de) Ein gegen Staphylococcus-Ganoderme-Lucidum-Extrakt enthaltendes antimikrobielles Mittel
TR199901209T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
WO2004034961A3 (en) Antimicrobial agents and uses thereof
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
DK0896532T3 (da) Acylurinstofforbindelser til behandling af coccidioidomycose i varmblodede dyr
DE69935662D1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati